The effectiveness of this medicine may be altered if you also take:
-metoclopramide, domperidone, or ondansetron (medications for nausea and vomiting treatment).
-colestiramine (medication that reduces cholesterol in the blood).
Your doctor will know which medications are safe to use with this medicine.
Tramadol/Paracetamol Qualigen with food, and alcohol
This medicine may make you feel drowsy. Alcohol may make you feel drowsy, so it is recommended not to take alcohol while taking this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using
this medicine.
Pregnancy
Because this medicine contains tramadol, it is not recommended to take this medicine during pregnancy or breastfeeding. If you become pregnant during treatment with this medicine, consult your doctor before taking the next tablet.
Breastfeeding
Tramadol is excreted in breast milk. For this reason, you should not take this medicine more than once during breastfeeding or, if you take it more than once, you should stop breastfeeding.
Fertility
Based on human experience, it is not suggested that tramadol affects the fertility of men and women. There are no data available on the combination of tramadol and paracetamol in fertility.
Driving and operating machinery
Ask your doctor if you can drive or operate machinery during treatment with this medicine. It is essential to observe how this medicine affects you before driving or operating machinery. Do not drive or operate machinery if you feel drowsy, dizzy, have blurred vision, or double vision, or have difficulty concentrating. Be especially careful at the start of treatment, after increasing the dose, after changing the formulation, and/or when taking it with other medications.
Tramadol/Paracetamol Qualigen contains sodium
This medicine contains lessthan 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will explain to you what you can expect from the use of Tramadol/Paracetamol Qualigen, when and for how long you should use it, when you should contact your doctor, and when you should stop it (see also section 2).
You should take tramadol/paracetamolfor the shortest time possible.
The dose should be adjusted to the intensity of the pain and your individual sensitivity. Normally, you should use the lowest dose possible that produces pain relief.
Use in children
This medication is not recommended for use in children under 12 years old.
Use in adults
Unless your doctor prescribes something different, the recommended starting dose for adults and adolescents over 12 years old is 1 tablet.
If necessary, you can increase the dose as recommended by your doctor. The shortest interval between doses should be at least 6 hours.
Do not take more than 4 tablets of tramadol/paracetamol Qualigen 75 mg/650 mg per day.
Do not take Tramadol/Paracetamol Qualigen more frequently than your doctor has indicated.
Older patients
In older patients (over 75 years old), the elimination of tramadol may be slow. If this is your case, your doctor may recommend prolonging the dosing intervals.
Patients with liver or kidney insufficiency/patients on dialysis
If you have a severe liver or kidney disease, treatment with this medication is not recommended. If you have moderate liver or kidney disease, your doctor may prolong the dosing intervals.
Administration form
This medication is presented in the form of tablets for oral administration.
Tramadol/Paracetamol Qualigen tablets can be divided into two equal halves.
Tablets should be swallowed with a sufficient amount of liquid and should not be broken or chewed.
If you estimate that theeffect ofTramadol/Paracetamol Qualigen istoo strong (e.g., youfeel verysleepy or havedifficulty breathing)or tooweak (e.g., youdo not have adequatepain relief),inform your doctor.
If you take more Tramadol/Paracetamol Qualigen than you should
If you have taken more tramadol/paracetamol than you should, even if you feel well, consult your doctor or pharmacist immediately, as there is a risk of severe liver damage that may only become apparent later.
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone: 91 562 04 20.
If you forgot to take Tramadol/Paracetamol Qualigen
If you forgot to take a dose of tramadol/paracetamol, it is likely that the pain will recur.
Do not take a double dose to compensate for the missed doses, simply continue taking the tablets as usual.
If you interrupt the treatment with Tramadol/Paracetamol Qualigen
You should not stop taking this medication suddenly unless your doctor tells you to. If you want to stop taking your medication, talk to your doctor first, especially if you have been taking it for a long time. Your doctor will inform you when and how to stop it, which can be done by gradually reducing the dose to reduce the likelihood of unnecessary side effects (withdrawal symptoms).
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common (may affect more than 1 in 10 people)
Common (may affect 1 in 10 people)
Rare (may affect 1 in 100 people)
Rare (may affect 1 in 1,000 people)
Frequency not known (cannot be estimated from available data)
The following adverse effects recognized have been reported by people who have taken medications containing only tramadol or only paracetamol. However, if you experience any of these symptoms while taking this medication, please inform your doctor:
In rare cases, using a medication like tramadol can make you dependent on it, making it difficult to stop taking it.
In rare instances, people who have been taking tramadol for some time may feel unwell if they stop treatment abruptly. They may feel agitated, anxious, nervous, or shaky. They may be hyperactive, have difficulty sleeping, and experience gastrointestinal and intestinal disorders. Very few people may also experience panic attacks, hallucinations, unusual perceptions such as itching, tingling, and numbness, and ear noises (tinnitus). If you experience any of these symptoms after stopping treatment with this medication, please consult your doctor.
In exceptional cases, blood tests may reveal certain abnormalities, such as low platelet count, which may result in nasal or gum bleeding.
In very rare instances, severe skin reactions with paracetamol have been reported.
Cases of rare respiratory depression with tramadol have been reported.
Reporting of adverse effects
If you experience any type of adverse effect, please consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus.
You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Store this medication in a safe and protected place where other people cannot access it. It may cause serious harm and be fatal to individuals who have not been prescribed it.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging, bottle, and blister pack, after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
-The active principles are hydrochloride of tramadol and paracetamol.
-Each film-coated tablet contains 75 mg of hydrochloride of tramadol and 650 mg of paracetamol.
-The other components are:
Core of the tablet:
Maize pregelatinized starch, stearic acid, povidone, crospovidone, microcrystalline cellulose, carboxymethyl starch sodium Type A, hydroxypropyl cellulose, magnesium stearate of vegetable origin.
Coating:
OPADRY yellow 15B82958 (hypromellose, macrogol 400, titanium dioxide (E171), iron oxide yellow (E172), polysorbate 80).
Appearance of the product and contents of the packaging
Tramadol/Paracetamol Qualigen 75 mg/650 mg film-coated tablets, are presented in the form of film-coated tablets, scored, oblong, biconvex, and yellow in color, packaged in PVC-white opaque/Al and PVC/PVDC-white opaque/Al blisters.
This medicine is presented in packaging of 20 and 60 tablets.
Only some sizes of packaging may be commercially marketed.
Holder of the marketing authorization
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
Responsible for manufacturing
Farmalider, S.A.
C/Aragoneses, 2
28108 Alcobendas
Madrid - Spain
Or
Toll Manufacturing Services, S.A.
C/Aragoneses, 2
28108 Alcobendas
Madrid - Spain
Revision date of this leaflet: February 2025
The detailed information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.